Skip to main content
. 2015 Oct 30;106(11):1582–1589. doi: 10.1111/cas.12813

Figure 1.

Figure 1

Kaplan–Meier plots of the association of the presence of total PIK3CA mutations of cfDNA with RFS: (a) BCSS and (b) the entire cohort. When the presence of total PIK3CA mutations of cfDNA was defined as either positive or negative, positive cases seemed to have a longer survival than negative ones in log‐lank test: (a) RFS, P = 0.0072; (b) BCSS, P = 0.016. BCSS, breast cancer‐specific survival; cfDNA, cell‐free DNA; RFS, relapse‐free survival.